Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014 - New Market Research Report

Boston, MA -- (SBWIRE) -- 08/07/2014 -- GlobalData's clinical trial report, "Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2014" provides data on the Relapsing Multiple Sclerosis (RMS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Relapsing Multiple Sclerosis (RMS). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Relapsing Multiple Sclerosis (RMS). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.